Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
abbvie
access biotechnology
access industries
anemia
astellas pharma
atlas venture
atlas ventures
audentes therapeutics
avidity biosciences
blood diseases
blood disorders
bluebird bio
brian macdonald
disc medicine
drug development
duchenne muscular dystrophy
dyne therapeutics
elizabeta nemeth
facioscapulohumeral muscular dystrophy
fda
financing
gene therapy
incubation
joshua brumm
kaleido biosciences
licensing
merganser biotech
muscular dystrophy
myotonic dystrophy type 1
national top stories
new york blog main
newco
novo nordisk
What
having
2
×
advance
ago
anemia
biotechs
blood
body
carry
cells
considering
data
disc
diseases
drug
dyne
early
expected
experimental
eyes
genetic
health
humans
ipo
ipos
iron
launches
lead
little
long
lungs
medicine
medicines
muscle
need
new
oxygen
problems
rare
reach
red
Language
unset
Current search:
having
×
boston
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
